{"id":"sertraline-omega-3","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Insomnia"},{"rate":"5-10%","effect":"Dry mouth"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Sertraline works by blocking the reabsorption of serotonin in the brain, leading to increased levels of this neurotransmitter. Omega-3 fatty acids, particularly EPA and DHA, have been shown to reduce inflammation and may have a role in improving mood and cognitive function.","oneSentence":"Sertraline is a selective serotonin reuptake inhibitor (SSRI) that increases serotonin levels in the brain, while omega-3 fatty acids have anti-inflammatory properties.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:34:11.087Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder"},{"name":"Generalized anxiety disorder"}]},"trialDetails":[{"nctId":"NCT05646693","phase":"PHASE2","title":"Effect of Combined Antioxidant Therapy on Oxidative Stress Markers and Inflammatory Cytokines in Patients With Tinnitus","status":"UNKNOWN","sponsor":"University of Guadalajara","startDate":"2022-12-01","conditions":"Tinnitus, Subjective, Tinnitus, Bilateral, Antioxidant Therapy","enrollment":58},{"nctId":"NCT02021669","phase":"PHASE2","title":"Omega-3 for Depression and Other Cardiac Risk Factors - 2","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2014-05-14","conditions":"Depression","enrollment":144},{"nctId":"NCT00116857","phase":"PHASE3","title":"Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2005-02","conditions":"Cardiovascular Diseases, Depression, Heart Diseases","enrollment":122}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":30,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Sertraline/omega-3","genericName":"Sertraline/omega-3","companyName":"Washington University School of Medicine","companyId":"washington-university-school-of-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sertraline is a selective serotonin reuptake inhibitor (SSRI) that increases serotonin levels in the brain, while omega-3 fatty acids have anti-inflammatory properties. Used for Major depressive disorder, Generalized anxiety disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}